Prognostic impact of clinical factors in MSI-H/dMMR gastrointestinal tumors treated with immune checkpoint inhibitors: results from a multicenter real-world study.

ESMO Real World Data Digit Oncol · 2026 · PMC13040892 · PMID 41930293

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

showed a trendP = 0.087so close (0.05 < p ≤ 0.1)

Primary tumor resection was associated with longer OS (HR 2.13, 95% CI 1.16-3.92, P = 0.012) and showed a trend toward better PFS ( P = 0.087).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.